Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.02 USD | +2.79% | -11.30% | -29.66% |
05-07 | Transcript : Rigel Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 07, 2024 | |
05-07 | Earnings Flash (RIGL) RIGEL PHARMACEUTICALS Posts Q1 Revenue $29.5M, vs. Street Est of $31.5M | MT |
Chart: Technical Analysis
Technical analysis trends
Short Term | Mid-Term | Long Term | |
---|---|---|---|
Trend | Bearish | Neutral | Neutral |
Resistance | 1.140 | 1.570 | 1.680 |
Spread/Res. | -10.53% | -35.03% | -39.29% |
Spread/Supp. | +2.79% | +28.46% | +39.69% |
Support | 0.9923 | 0.7940 | 0.7302 |
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- RIGL Stock
- Charts Rigel Pharmaceuticals, Inc.